Canon Inc.
Canon Inc. (CAJPY) Financial Performance & Income Statement Overview
Analyze Canon Inc. (CAJPY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Canon Inc. (CAJPY) Income Statement & Financial Overview
Explore comprehensive income reports for Canon Inc. CAJPY, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1058.40B | $1273.71B | $1079.81B | $1167.79B |
| Cost of Revenue | $557.48B | $677.006B | $563.45B | $616.20B |
| Gross Profit | $500.92B | $596.70B | $516.36B | $551.59B |
| Gross Profit Ratio | $0.47 | $0.47 | $0.48 | $0.47 |
| R&D Expenses | $80.79B | $91.55B | $81.29B | $85.06B |
| SG&A Expenses | $323.61B | $356.94B | $336.91B | $348.14B |
| Operating Expenses | $404.40B | $613.59B | $418.20B | $433.20B |
| Total Costs & Expenses | $961.88B | $1290.59B | $981.64B | $1049.39B |
| Interest Income | $3.65B | $4.04B | $3.83B | $3.79B |
| Interest Expense | $1.36B | $1.26B | $1.01B | $846.00M |
| Depreciation & Amortization | $52.90B | $62.68B | $59.44B | $58.89B |
| EBITDA | $153.11B | $210.89B | $149.78B | $177.28B |
| EBITDA Ratio | $0.14 | $0.17 | $0.14 | $0.15 |
| Operating Income | $96.52B | -$16.88B | $98.16B | $118.39B |
| Operating Income Ratio | $0.09 | -$0.01 | $0.09 | $0.10 |
| Other Income/Expenses (Net) | $2.33B | $7.28B | -$8.84B | $13.83B |
| Income Before Tax | $98.84B | -$9.61B | $89.32B | $132.22B |
| Income Before Tax Ratio | $0.09 | -$0.008 | $0.08 | $0.11 |
| Income Tax Expense | $21.19B | $40.63B | $15.89B | $36.75B |
| Net Income | $72.23B | -$58.54B | $68.76B | $89.86B |
| Net Income Ratio | $0.07 | -$0.05 | $0.06 | $0.08 |
| EPS | $77.27 | -$62.02 | $71.96 | $90.98 |
| Diluted EPS | $77.22 | -$62.02 | $71.85 | $90.94 |
| Weighted Avg Shares Outstanding | $934.84M | $943.99M | $955.60M | $987.66M |
| Weighted Avg Shares Outstanding (Diluted) | $935.39M | $943.99M | $957.04M | $988.08M |
The company's financials show resilient growth, with revenue advancing from $1167.79B in Q2 2024 to $1058.40B in Q1 2025. Gross profit remained healthy with margins at 47% in Q1 2025 compared to 47% in Q2 2024. Operating income hit $96.52B last quarter, sustaining a consistent 9% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $153.11B. Net income rose to $72.23B, while earnings per share reached $77.27. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan